<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>ISOLATION OF STIGMASTEROL FROM Piptadeniastrum africanum (HOOK. F.) AND ITS MODULATORY EFFECT ON MITOCHONDRIAL-MEDIATED CELL DEATH IN LIVER AND COLONIC TOXICITY IN MICE</title>
<link href="http://hdl.handle.net/123456789/2265" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/123456789/2265</id>
<updated>2026-04-20T05:56:46Z</updated>
<dc:date>2026-04-20T05:56:46Z</dc:date>
<entry>
<title>ISOLATION OF STIGMASTEROL FROM Piptadeniastrum africanum (HOOK. F.) AND ITS MODULATORY EFFECT ON MITOCHONDRIAL-MEDIATED CELL DEATH IN LIVER AND COLONIC TOXICITY IN MICE</title>
<link href="http://hdl.handle.net/123456789/2266" rel="alternate"/>
<author>
<name>OLOJO, Folake Olayinka</name>
</author>
<id>http://hdl.handle.net/123456789/2266</id>
<updated>2024-05-23T08:28:53Z</updated>
<published>2023-04-01T00:00:00Z</published>
<summary type="text">ISOLATION OF STIGMASTEROL FROM Piptadeniastrum africanum (HOOK. F.) AND ITS MODULATORY EFFECT ON MITOCHONDRIAL-MEDIATED CELL DEATH IN LIVER AND COLONIC TOXICITY IN MICE
OLOJO, Folake Olayinka
Hepatocellular and colonic damage are fatal outcomes arising from liver and colon toxicity.&#13;
Modulation of mitochondrial-mediated cell death is a strategy in these diseases management. The&#13;
use of synthetic drugs in the treatment of these diseases presents several side effects. In folklore,&#13;
Piptadeniastrum africanum (PA) is used for the treatment of these disorders but the mechanism has&#13;
not been explored. This study was designed to investigate the role of bioactive compound(s) purified&#13;
from PA on liver and colon damage via the modulation of mitochondrial-dependent cell death.&#13;
The istem ibark iof iPiptadeniastrum iafricanum iwas icollected ifrom ia iforest iat iIbadan,&#13;
identified iat ithe idepartment iof iBotany, iUniversity iof iIbadan i(UIH-22562) iair-dried,&#13;
pulverised iand isoaked iin iabsolute imethanol ito iobtain iits iextract i(CMEPA). i iThe iCMEPA&#13;
was ifractionated iusing in-hexane, ichloroform, iethyl iacetate iand imethanol ito iobtain itheir&#13;
respective ifractions i(HFPA, iCFPA, iEFPA iand iMFPA) iwhich iwere itested ion imitochondrial&#13;
permeability itransition i(mPT) ipore iopening iand iATPase iactivity i(in ivitro). i iThe ieffects iof&#13;
the ifractions iof iPA ion iliver iand icolon itissues iwere ievaluated iin istudy i1. iTwenty imice&#13;
(20±2g; in=5) iwere igrouped iand itreated ias ifollows, igroups i1 i(vehicle), i2, i3 iand i4 iwere&#13;
treated iintraperitoneally iwith i25, i50 iand i100 img/kg iof iEFPA ionce idaily ifor i14 idays iand&#13;
liver imPT iassayed. iThe iEFPA iwas ipurified iusing icolumn ichromatography ito iobtain ia ipure&#13;
compound iwhich iwas icharacterised ias istigmasterol iby ispectroscopic itechniques. iIn istudy i2,&#13;
forty-two imice iwere igrouped i(n=7), itreated iwith iDextran iSulphate iSodium i(DSS) iand&#13;
Benzo{a}Pyrene i(BaP) ifor i10 days as follows, groups 1 (vehicle), 2 (oral 4% DSS), 3 (125mg/kg&#13;
BaP), 4 (DSS+BaP), 5 (DSS+BaP and 200mg/kg of stigmasterol) and 6 (DSS+BaP and 400mg/kg&#13;
of stigmasterol). The mice were sacrificed and colon samples prepared. Tumor Necrosis Factor-α&#13;
(TNF-α), Interleukin 6 (IL-6), p53, Caspases 9 (C9), Bax, Bcl-2, were performed on the colon using&#13;
immunohistochemistry. All data were analysed using descriptive statistics and ANOVA at α0.05.&#13;
In vitro, EFPA had the highest induction of mPT pore opening (3.80, 5.60, 6.40, 8.10 and 8.90 folds)&#13;
at 20, 60, 100, 140 and 180µg/ml, respectively and enhanced ATPase activity (0.20±0.01, 0.35±0.10,&#13;
0.40±0.10, 0.45±0.20 and 5.20±0.80µmole/Pi/mg/protein/min), relative to the vehicle&#13;
(0.05µmole/Pi/mg/protein/min), respectively. In vivo, EFPA caused mPT induction of 2.50, 4.90 and&#13;
6.90 folds at 25, 50 and 100mg/kg, respectively. The toxicant groups (DSS, BaP and DSS+BaP),&#13;
relative to the vehicle significantly increased TNF-α (40.00±1.20%, 30.00±0.90%, 34.00±1.10% vs&#13;
15.00±0.70%), IL-6 (160.00±3.50%, 110.00±2.20%, 120.00±1.50% vs 60.00±1.50%) and p53&#13;
(80.00±2.30%, 70.00±1.10%, 85.00±2.20% vs 25.00±0.90%) However, stigmasterol (200 and&#13;
400mg/kg), relative to DSS+BaP significantly attenuated TNF-α (12.00±0.09%, 13.00±0.10% vs&#13;
34.00±1.10%), IL-6 (53.00±1.30%, 50.00±1.20% vs 120.00±1.50%), p53 (40.00±2.20%,&#13;
50.00±1.70% vs 85.00±2.20%). The DSS, BaP and DSS+BaP, relative to the vehicle increased C9&#13;
(1.10±0.10, 0.90±0.01, 1.10±0.10ng/ml vs 0.01ng/ml), Bax (120.00%, 100.00%, 90.00% vs&#13;
110.00%) and reduced Bcl-2 (80.00%, 75.00%, 75.00% vs 90.00%) which were modulated by&#13;
stigmasterol.&#13;
Stigmasterol isolated from the Piptadeniastrum africanum modulated mitochondrial-mediated cell&#13;
death via a decrease in pro-inflammatory cytokines and levels of pro-apoptotic proteins.
</summary>
<dc:date>2023-04-01T00:00:00Z</dc:date>
</entry>
</feed>
